Low-dose, Triple Combination Drug Effectively Lowers Blood Pressure
Findings demonstrated that early use of a low-dose combination blood pressure drug is safe and more effective than current treatments.
A new study, presented today at the 67th American College of Cardiology Annual Scientific Session, concluded that initial use of low-dose triple combination therapy is a safe and highly effective strategy to rapidly achieve blood pressure control compared with usual care.
The Triple Pill, which combines low doses of 3 blood pressure-lowering medications, was found to significantly increase the number of patients reaching blood pressure targets when compared with usual care. Researchers found no significant increase in adverse effects with the combination therapy.
“Most people — 70% — reached blood pressure targets with the Triple Pill,” lead study author Ruth Webster, MBBS, The George Institute for Global Health at the University of New South Wales, said in a statement. “The benefits were seen straight away and maintained until 6 months, whereas with usual care control rates were 55% at 6 months and even lower earlier in the trial.”
For more information, please visit MDMag.com.
